#MBRXUpdates — Moleculin to Participate in Four Upcoming Healthcare Conferences
#MBRXUpdates — Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model https://t.co/1c2Q6TTZaO
Members of our management will present at the virtual H.C. Wainwright BioConnect 2021 Conference on Monday, January… https://t.co/zz51cveglb
The FDA has granted Orphan Drug Designation to Annamycin for treatment of soft tissue sarcomas. This is now the sec… https://t.co/fzsBbDTFDi
Moleculin to present animal data demonstrating highly improved activity of Annamycin against acute myeloid leukemia… https://t.co/yQSHzaQ27U
The FDA approves 3 "Rare Pediatric Disease" designations for our drug candidate WP1066. Please read our press relea… https://t.co/uJm5JZO9Th
We have entered into an agreement with the University of Campinas in São Paulo, Brazil to further enable collaborat… https://t.co/lcc1gXtXZZ
Moleculin will participate in a panel at ROTH Capital's healthcare event titled, "COVID-19 Therapeutics in Developm… https://t.co/xRx2itnYlU
We are pleased to announce positive interim results in our adult glioblastoma clinical trial. Please read our press… https://t.co/7DQrsliCRY
Similar Businesses
